Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Healthcare (Basel, Switzerland)|November 24, 2022
Population Based Average Parotid Gland Volume and Prevalence of Incidental Tumors in T1-MRITina Brzoska, Till Ittermann, Friedrich Ihler, et al.
The Oncologist|February 3, 2026
Malnutrition in gastrointestinal cancer manifests before systemic therapy and is associated with fatigue and reduced physical quality of lifeMats L Wiese, Lena Schwarz, Sabrina von Rheinbaben, et al.
Plos One|August 22, 2024
Feasibility of individualized home exercise programs for patients with head and neck cancer-study protocol and first results of a multicentre single-arm intervention trial (OSHO #94)Sabine Felser, Julia Rogahn, Änne Glass, et al.
Frontiers in Oncology|June 24, 2025
Individualized home training in head and neck cancer patients is safe and has positive short- and medium-term effects -results of a multicenter, single-arm intervention trial (OSHO #94)Sabine Felser, Lars A Bonke, Änne Glass, et al.
NPJ Precision Oncology|August 5, 2025
Inflammation and limited adaptive immunity predict worse outcomes on immunotherapy in head and neck cancerLisa Paschold, Christoph Schultheiss, Paul Schmidt-Barbo, et al.
Frontiers in Oncology|February 22, 2024
Tolerability and efficacy of the cancer vaccine UV1 in patients with recurrent or metastatic PD-L1 positive head and neck squamous cell carcinoma planned for first-line treatment with pembrolizumab - the randomized phase 2 FOCUS trialAnna Brandt, Christoph Schultheiss, Konrad Klinghammer, et al.
Cancers|April 12, 2022
Tissue Microarray Analyses Suggest Axl as a Predictive Biomarker in HPV-Negative Head and Neck CancerChia-Jung Busch, Christian Hagel, Benjamin Becker, et al.
Med (New York, N.Y.)|April 12, 2025
UV1 vaccination in pembrolizumab-treated patients with recurrent or metastatic head and neck cancer: A randomized multicenter phase 2 trialAnna Brandt, Konrad Klinghammer, Christoph Schultheiss, et al.
Pageof 2